Literature DB >> 22850720

T-cell therapy for viral infections following transplantation: why stop at three viruses?

John A Barrett.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22850720      PMCID： PMC3412499          DOI： 10.1038/mt.2012.138

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  17 in total

1.  In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive cord blood lymphocytes.

Authors:  Kyung-Duk Park; Luciana Marti; Joanne Kurtzberg; Paul Szabolcs
Journal:  Blood       Date:  2006-05-04       Impact factor: 22.113

2.  Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals.

Authors:  Ann M Leen; G Doug Myers; Uluhan Sili; M Helen Huls; Heidi Weiss; Kathryn S Leung; George Carrum; Robert A Krance; Chung-Che Chang; Jeffrey J Molldrem; Adrian P Gee; Malcolm K Brenner; Helen E Heslop; Cliona M Rooney; Catherine M Bollard
Journal:  Nat Med       Date:  2006-09-24       Impact factor: 53.440

Review 3.  How we treat cytomegalovirus in hematopoietic cell transplant recipients.

Authors:  Michael Boeckh; Per Ljungman
Journal:  Blood       Date:  2009-03-18       Impact factor: 22.113

Review 4.  How I treat EBV lymphoproliferation.

Authors:  Helen E Heslop
Journal:  Blood       Date:  2009-09-01       Impact factor: 22.113

5.  Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation.

Authors:  Tobias Feuchtinger; Susanne Matthes-Martin; Celine Richard; Thomas Lion; Monika Fuhrer; Klaus Hamprecht; Rupert Handgretinger; Christina Peters; Friedhelm R Schuster; Robert Beck; Michael Schumm; Ramin Lotfi; Gerhard Jahn; Peter Lang
Journal:  Br J Haematol       Date:  2006-07       Impact factor: 6.998

6.  Donor T cells to treat EBV-associated lymphoma.

Authors:  H E Heslop; M K Brenner; C M Rooney
Journal:  N Engl J Med       Date:  1994-09-08       Impact factor: 91.245

Review 7.  Principles for adoptive T cell therapy of human viral diseases.

Authors:  S R Riddell; P D Greenberg
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

8.  Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes.

Authors:  Patrick J Hanley; Conrad Russell Young Cruz; Barbara Savoldo; Ann M Leen; Maja Stanojevic; Mariam Khalil; William Decker; Jeffrey J Molldrem; Hao Liu; Adrian P Gee; Cliona M Rooney; Helen E Heslop; Gianpietro Dotti; Malcolm K Brenner; Elizabeth J Shpall; Catherine M Bollard
Journal:  Blood       Date:  2009-05-14       Impact factor: 22.113

9.  Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones.

Authors:  S R Riddell; K S Watanabe; J M Goodrich; C R Li; M E Agha; P D Greenberg
Journal:  Science       Date:  1992-07-10       Impact factor: 47.728

Review 10.  The challenge of respiratory virus infections in hematopoietic cell transplant recipients.

Authors:  Michael Boeckh
Journal:  Br J Haematol       Date:  2008-09-10       Impact factor: 6.998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.